Estrace Cream
Product Images NDC 50090-2321

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Estrace (NDC 50090-2321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Estrace (estradiol Vaginal Cream, Usp, 0.01%) Contains 0.1 mg Estradiol In A Nonliquefying Base Containing Purified Water, Propylene Glycol, Stearyl Alcohol, White Ceresin Wax, Mono- And Di-glycerides, Hypromellose 2208 (4000 Cps), Sodium Lauryl Sulfate, Methylparaben, Edetate Di-sodium And Tertiary-butylhydroquinone. Estradiol Is Chemically Described As Estra-1,3,5(10)-triene-3, 17(beta)-diol. It Has An Empirical Formula Of C18h24o2 And Molecular Weight Of 272.37. (Estrace Cream 01)

The Structural Formula For Estrace (estradiol Vaginal Cream, Usp, 0.01%) Contains 0.1 mg Estradiol In A Nonliquefying Base Containing Purified Water, Propylene Glycol, Stearyl Alcohol, White Ceresin Wax, Mono- And Di-glycerides, Hypromellose 2208 (4000 Cps), Sodium Lauryl Sulfate, Methylparaben, Edetate Di-sodium And Tertiary-butylhydroquinone. Estradiol Is Chemically Described As Estra-1,3,5(10)-triene-3, 17(beta)-diol. It Has An Empirical Formula Of C18h24o2 And Molecular Weight Of 272.37. (Estrace Cream 01)
Chemical structure diagram of estradiol, the active ingredient in ESTRACE vaginal cream. The diagram shows the molecular framework with labeled functional groups including hydroxyl (OH) groups and a methyl (CH3) group.*
FDA Label Image

Table 2 -relative And Absolute Risk Seen In The Estrogen Plus Progestin Substudy Of Whi At An Average Of 5.6 Years A,b (Estrace Cream 02)

Table 2 -relative And Absolute Risk Seen In The Estrogen Plus Progestin Substudy Of Whi At An Average Of 5.6 Years A,b (Estrace Cream 02)
A data table presenting relative risks and absolute risks per 10,000 women-years for various health events comparing CE/MPA treatment versus placebo. The table includes events such as CHD events, strokes, cancers, fractures, overall mortality, and a global index, with respective risk estimates, confidence intervals, and event counts for CE/MPA and placebo groups.*
FDA Label Image

Allergan (Estrace Cream 03)

FDA Label Image

Label Image (Lbl500902321)

Label Image (Lbl500902321)
Packaging label for ESTRACE estradiol vaginal cream 0.1 mg/g by A-S Medication Solutions. The label states the product type as human prescription drug, lists the package size as 1.5 oz (42.5 g) tube, and includes storage instructions to keep at room temperature below 86 degrees Fahrenheit. The package insert dosage information is referenced by a barcode on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.